open🌐 RFPMart: USA (all categories)http://www.rfpmart.com/1198200-us-fed-s299--fy27-pharmaceutical-reverse-distribution-services.html
US-FED-00000399934 - S299--FY27 Pharmaceutical Reverse Distribution Services - Deadline November 18,2026
Description
SOURCES SOUGHT NOTICE PHARMACEUTICAL REVERSE DISTRIBUTION SERVICES ORLANDO VA HEALTH CARE SYSTEM (OVAHCS) Notice Type: Sources Sought (Market Research) Notice ID: 36C24827Q0037 Agency: Department of Veterans Affairs Contracting Office: Network Contracting Office 8 (NCO 8) Issuing Office Address: Orlando VA Healthcare System, 13800 Veterans Way, Orlando, FL 32827 NAICS Code: 562119 Size Standard: 250 Employees Product/Service Code: S299 Housekeeping Other Place of Performance: Multiple sites within OVAHCS (Orlando, Daytona Beach, and Viera, FL) Response Due Date: November 18, 2026, 3:00 PM 1. DISCLAIMER THIS IS A SOURCES SOUGHT NOTICE ONLY. This is not a solicitation announcement, a request for proposals, a request for quotes, or an obligation on the part of the Government to acquire any products or services. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. The Government will not pay for any information provided in response to this notice or for the Government`s use of such information. All costs associated with responding to this Sources Sought are solely at the responder`s expense. The purpose of this notice is to conduct market research to identify qualified sources including Service–Disabled Veteran–Owned Small Businesses (SDVOSB), Veteran–Owned Small Businesses (VOSB), and other small business categories capable of providing the services described herein. Responses will assist the Government in determining the appropriate acquisition strategy, including potential small business set–aside determinations under FAR Part 19 and 38 U.S.C. §§ 8127 8128 (VA Rule of Two). 2. BACKGROUND The Orlando VA Health Care System (OVAHCS) is required by federal regulation to remove all controlled and non–controlled substances that are expired, recalled, or otherwise determined to be unusable from active stock. These substances must be stored separately until destroyed, reverse distributed, or transferred to a DEA–licensed vendor for destruction, in accordance with 21 CFR Part 1317. OVAHCS is seeking to expand its current destruction–only capability to include pharmaceutical reverse distribution services for non–controlled substances that would otherwise result in lost manufacturer credit opportunities and incomplete inventory lifecycle control, while maintaining destruction capability for both controlled and non–controlled medications across all OVAHCS sites. The intended outcomes include: Recovery of financial credit for eligible non–controlled medications that are reverse distributed. Improved inventory management and reduced waste. Full lifecycle accountability for all medications. Strengthened compliance with VA, DEA, and federal requirements. 3. DESCRIPTION OF REQUIREMENT The Government is seeking a contractor licensed by the Drug Enforcement Administration (DEA) to provide flat–fee services to collect, transport, reverse distribute, and/or destroy controlled (Schedules I V) and non–controlled medications at OVAHCS facilities. Fees shall not be calculated as a percentage of credit returns under any circumstances. 3.1 Scope Highlights The Contractor shall provide: On–site processing of Schedule I V controlled substances and non–controlled substances (including expired, recalled, due–to–expire, or otherwise unusable medications). A minimum of four (4) on–site visits per calendar year at the Outpatient Clinics and Orlando VA Medical Center, with additional visits as directed by the COR. Response within ten (10) business days of a COR request. All shipping instructions, forms, labels, postage, DEA–approved tamper–proof pouches, and boxes required for shipment to the Contractor`s central processing facility. Chain–of–custody documentation, including DEA Form 41 for controlled substances, signed by the Pharmacist, Accountable Officer, and Contractor representative. Manufacturer return coordination, credit reconciliation, and Drug Supply Chain Security Act (DSCSA) compliance. A toll–free (800) number and a web–based service request ordering system. A web–based reporting portal that captures collection date, site, drug name, formulation/strength, NDC, quantity, manufacturer, estimated return value, actual return value, and status of each reverse distribution pickup. Initial orientation and training on all applicable reports and web–based systems. A written Substance Collection Plan and Substance Contingency Plan. 3.2 Applicable Regulatory Framework The Contractor shall comply with all applicable federal, state, and local regulations, including but not limited to: Controlled Substances Act (CSA) 21 CFR Part 1317 (DEA regulations for disposal of controlled substances) Drug Supply Chain Security Act (DSCSA) 21 CFR (Food & Drugs), 29 CFR (Hazardous Materials), 40 CFR (Environment), 49 CFR (Transportation) EPA, OSHA, FDA, DEA requirements 41 U.S.C. Chapter 67 (Service Contract Labor Standards) All applicable VA policies and facility–specific security requirements
Details?
- Posted
- Nov 16, 2026
- Response deadline
- Nov 18, 2026, 11:59 PM UTC (2d)
- Status
- open
- Jurisdiction
- RFPMart: USA (all categories)
- Reference #
- http://www.rfpmart.com/1198200-us-fed-s299--fy27-pharmaceutical-reverse-distribution-services.html
- Has Description
- true
- Item
- US-FED-00000399934 - S299--FY27 Pharmaceutical Reverse Distribution Services - Deadline November 18,2026 SOURCES SOUGHT NOTICE PHARMACEUTICAL REVERSE DISTRIBUTION SE
Similar open opportunities
See opportunities like this one
GovBidAlerts matches this solicitation to similar open bids across 114,000+ open bids from 2,500+ sources. Create a free account to unlock them.
Create free accountno credit card required
This listing is a summary from RFPMart: USA (all categories)'s open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.